India · Delayed Price · Currency is INR Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of INR 235.88 billion. The enterprise value is 209.13 billion.
| Market Cap | 235.88B |
| Enterprise Value | 209.13B |
Important Dates
The last earnings date was Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Jul 9, 2025 |
Share Statistics
| Current Share Class | 45.75M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 15.12M |
Valuation Ratios
The trailing PE ratio is 29.17 and the forward PE ratio is 31.57.
| PE Ratio | 29.17 |
| Forward PE | 31.57 |
| PS Ratio | 10.16 |
| PB Ratio | 5.59 |
| P/TBV Ratio | 6.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 25.86 |
| EV / Sales | 9.01 |
| EV / EBITDA | 27.05 |
| EV / EBIT | 29.29 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | n/a |
| Interest Coverage | 74.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.13% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 14.53M |
| Profits Per Employee | 5.06M |
| Employee Count | 1,598 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Pfizer has paid 2.64 billion in taxes.
| Income Tax | 2.64B |
| Effective Tax Rate | 24.64% |
Stock Price Statistics
The stock price has decreased by -13.14% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -13.14% |
| 50-Day Moving Average | 5,423.58 |
| 200-Day Moving Average | 4,901.25 |
| Relative Strength Index (RSI) | 41.29 |
| Average Volume (20 Days) | 3,460 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pfizer had revenue of INR 23.22 billion and earned 8.09 billion in profits. Earnings per share was 176.76.
| Revenue | 23.22B |
| Gross Profit | 14.95B |
| Operating Income | 7.14B |
| Pretax Income | 10.73B |
| Net Income | 8.09B |
| EBITDA | 7.38B |
| EBIT | 7.14B |
| Earnings Per Share (EPS) | 176.76 |
Balance Sheet
The company has 27.83 billion in cash and 1.08 billion in debt, giving a net cash position of 26.74 billion.
| Cash & Cash Equivalents | 27.83B |
| Total Debt | 1.08B |
| Net Cash | 26.74B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 42.17B |
| Book Value Per Share | 921.88 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 64.41%, with operating and profit margins of 30.75% and 34.83%.
| Gross Margin | 64.41% |
| Operating Margin | 30.75% |
| Pretax Margin | 46.22% |
| Profit Margin | 34.83% |
| EBITDA Margin | 31.81% |
| EBIT Margin | 30.75% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 165.00, which amounts to a dividend yield of 2.91%.
| Dividend Per Share | 165.00 |
| Dividend Yield | 2.91% |
| Dividend Growth (YoY) | 371.43% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 2.91% |
| Earnings Yield | 3.43% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |